LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
AstraZeneca’s share price is down 20% from September, so is it time for me to buy?
Investing Articles
I think this could be the best investment opportunity on the FTSE 100
Investing Articles
Here’s why the AstraZeneca share price dipped 3.7% in the FTSE 100 today
Investing Articles
The top 3 mistakes to avoid if the stock market crashes
Growth Shares
2 UK shares that could be significantly impacted by the new tariff rumours
Investing Articles
£10,000 invested in the FTSE 100 at the start of the year is now worth…
Investing Articles
Down 28% in 8 months, is AstraZeneca’s share price too cheap for me to pass up right now?
Investing Articles
Just opened a Stocks and Shares ISA? Here are 10 stocks to consider buying, according to AI
Investing Articles
I asked ChatGPT where the FTSE 100 will be in 6 months: here’s what it said…
Investing Articles
These FTSE shares may offer some safety as Trump slaps tariffs on trading partners
Investing Articles
3 top FTSE 100 shares to consider for a new ISA